- FOUNDATION
- |
- IPPE
- |
- PPFC
- |
- CONTACT
News Release
- Media Center Home /
- News Release View


For Immediate Release
U.S. Poultry & Egg Association
Tucker, Ga. - May 11, 2026
- Contact:
- Hannah Keck, 678.514.1979, hkeck@uspoultry.org, (USPOULTRY)
Development of U.S.-Strain Live and Inactivated Vaccines for Control of Avian Metapneumovirus Subtype B in Poultry
USPOULTRY and the USPOULTRY Foundation announce the completion of a research project that developed both live and inactivated vaccine candidates for avian metapneumovirus (aMPV) subtype B. The research is part of the Association’s comprehensive research program, which encompasses all phases of poultry and egg production and processing, and is made possible in part through proceeds from the International Poultry Expo, part of the International Production & Processing Expo.
Project # 745: Development of Live Attenuated and Killed Vaccines for Emerging Avian Metapneumovirus Subgroup B
(Dr. Sunil Kumar Mor, Animal Disease Research and Diagnostic Laboratory, South Dakota State University, Brookings, S.D.)
aMPV, a virus which causes an acute respiratory tract infection in turkeys and chickens, re-emerged in the U.S. poultry industry, rapidly spreading across key poultry-producing states and posing a significant threat to production. The Center for Veterinary Biologics granted conditional approval for imported vaccines based on European strains as an emergency measure in early 2025; however, no licensed live attenuated vaccines derived from U.S. strains are currently available.
A team of researchers, led by Dr. Sunil Mor, at South Dakota University, successfully developed both live and inactivated vaccine candidates for aMPV subtype B. One of the live vaccine candidates showed strong safety and provided complete protection in chickens, while the inactivated vaccine generated strong protective antibody responses. Both vaccine approaches performed well in commercial turkey poults, with the live vaccine offering the highest level of protection.
These results demonstrate strong potential for practical, field-ready tools to help control aMPV in poultry. Overall, the work supports the development of U.S.-based vaccines to reduce future disease impacts and economic losses in the poultry industry.
The research summary can be found on the USPOULTRY website. Information on other Association research may also be obtained by visiting the USPOULTRY website.
###
More Recent News
August 27, 2026
Poultry Industry Safety Innovators Encouraged to Apply for Frank Cruice Award
The Joint Poultry Industry Safety & Health Council is now accepting applications for the Frank Cruice Innovation in Safety & Health Award, recognizing poultry and egg industry organizat...
![]()
August 26, 2026
Poultry Leads the Way: Save the Date for the 2027 Latin American Poultry Summit
The 2027 Latin American Poultry Summit is set for Monday, Jan. 25, in Atlanta, Ga., USA. The event will be held in conjunction with the International Poultry Expo (IPE), part of the Internation...
August 25, 2026
The Future Starts Here: Apply for the 2027 IPPE Young Leaders Under 30 Award
Applications are now open for the 15th annual International Production & Processing Expo (IPPE) Young Leaders Under 30 Award, a program designed to recognize the next generation of industry...
![]()
General Info
Events & Meetings
People & Groups
- Affiliated States
- Air Cargo Committee
- Hen Council
- Industry Partners
- Poultry Protein & Fat Council
- USPOULTRY Foundation